FOR HEALTHCARE PROFESSIONALS
We want to ensure that physicians, researchers, and other healthcare professionals have access to complete, up-to-date, and balanced scientific information regarding gene therapy research and investigational therapies.
As a company, we are dedicated to developing novel treatments for patients suffering from rare and life-threatening neurological genetic diseases.
Please direct any of your medical inquiries to MedInfo@avexis.com
See our Expanding Access to Patients page to learn more about our Managed Access Program. You can also learn more by visiting our Research and Development page.
CLINICAL TRIAL INFORMATION
Clinicaltrials.gov is a database of privately and publicly funded clinical studies conducted around the world.
Learn about AveXis-sponsored research studies for spinal muscular atrophy (SMA).
MANAGED ACCESS PROGRAM
Patients with serious or life-threatening diseases or conditions sometimes seek medical products that are not yet approved or available in their country. AveXis’ “Managed Access” addresses this need by making certain investigational or unapproved treatments available to eligible patients. Click here to learn more
REPORT ADVERSE EVENTS OR PRODUCT COMPLAINTS
To report Adverse Events or Product Quality Complaints, please call AveXis Medical Information at +351 30 880 0322.